CS
TECX

Credit Suisse’s Tectonic Therapeutic TECX Stock Holding History

Credit Suisse’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed – – 4349
2022
Q2 		$0 Buy
+2
New +$24 ﹤0.01% 4383
2021
Q4 		– Sell
-1,647
Closed -$110K – 4696
2021
Q3 		$110K Buy
1,647
+226
+16% +$18.5K ﹤0.01% 4313
2021
Q2 		$151K Sell
1,421
-472
-25% -$56K ﹤0.01% 4326
2021
Q1 		$288K Sell
1,893
-2,043
-52% -$332K ﹤0.01% 4011
2020
Q4 		$657K Buy
3,936
+901
+30% +$160K ﹤0.01% 3643
2020
Q3 		$474K Sell
3,035
-315
-9% -$63.5K ﹤0.01% 3430
2020
Q2 		$701K Buy
3,350
+487
+17% +$100K ﹤0.01% 3121
2020
Q1 		$535K Buy
2,863
+1,720
+150% +$405K ﹤0.01% 3069
2019
Q4 		$277K Sell
1,143
-161
-12% -$31K ﹤0.01% 3852
2019
Q3 		$221K Buy
+1,304
New +$295K ﹤0.01% 3832

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse's TECX Position: Q3 2022 in Review

Credit Suisse sold out of Tectonic Therapeutic (TECX) in Q3 2022, closing a stake of 2 shares.

Credit Suisse first reported a position in TECX in Q3 2019 and held it in 10 quarters. The position peaked at $701K in Q2 2020. 54 funds tracked by Wall St. Rank hold TECX as of Q3 2022.

  • Credit Suisse reported no remaining Tectonic Therapeutic position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 2 Tectonic Therapeutic shares in Q3 2022.
  • Credit Suisse first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 10 quarters.
  • Credit Suisse's Tectonic Therapeutic position peaked at $701K in Q2 2020.
  • 54 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.